Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/35434
Título: | Evidence-based practice within nutrition: what are the barriers for improving the evidence and how can they be dealt with? | Autores/as: | Laville, Martine Segrestin, Berenice Alligier, Maud Ruano-Rodríguez, Cristina Serra-Majem, Lluis Hiesmayr, Michael Schols, Annemie La Vecchia, Carlo Boirie, Yves Rath, Ana Neugebauer, Edmund A. M. Garattini, Silvio Bertele, Vittorio Kubiak, Christine Demotes-Mainard, Jacques Jakobsen, Janus C. Djurisic, Snezana Gluud, Christian |
Clasificación UNESCO: | 3206 Ciencias de la nutrición | Palabras clave: | Randomised clinical trials Evidence-based clinical practice Evidence-based medicine Assessment Specific barriers, et al. |
Fecha de publicación: | 2017 | Publicación seriada: | Trials | Resumen: | Background: Evidence-based clinical research poses special barriers in the field of nutrition. The present review summarises the main barriers to research in the field of nutrition that are not common to all randomised clinical trials or trials on rare diseases and highlights opportunities for improvements. Methods: Systematic academic literature searches and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. Results: Many nutrients occur in multiple forms that differ in biological activity, and several factors can alter their bioavailability which raises barriers to their assessment. These include specific difficulties with blinding procedures, with assessments of dietary intake, and with selecting appropriate outcomes as patient-centred outcomes may occur decennia into the future. The methodologies and regulations for drug trials are, however, applicable to nutrition trials. Conclusions: Research on clinical nutrition should start by collecting clinical data systematically in databases and registries. Measurable patient-centred outcomes and appropriate study designs are needed. International cooperation and multistakeholder engagement are key for success. | URI: | http://hdl.handle.net/10553/35434 | ISSN: | 1745-6215 | DOI: | 10.1186/s13063-017-2160-8 | Fuente: | Trials [ISSN 1745-6215], v. 18, article number 425 |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.